[go: up one dir, main page]

CN109837289B - Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto - Google Patents

Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto Download PDF

Info

Publication number
CN109837289B
CN109837289B CN201910233452.7A CN201910233452A CN109837289B CN 109837289 B CN109837289 B CN 109837289B CN 201910233452 A CN201910233452 A CN 201910233452A CN 109837289 B CN109837289 B CN 109837289B
Authority
CN
China
Prior art keywords
bacillus natto
self
agglutination
culture
transformant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910233452.7A
Other languages
Chinese (zh)
Other versions
CN109837289A (en
Inventor
刘艳
胡润
薛正莲
杨超英
王洲
钱森和
胡刘秀
李松
杨自名
冯静静
高越
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Polytechnic University
Original Assignee
Anhui Polytechnic University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Polytechnic University filed Critical Anhui Polytechnic University
Priority to CN201910233452.7A priority Critical patent/CN109837289B/en
Publication of CN109837289A publication Critical patent/CN109837289A/en
Application granted granted Critical
Publication of CN109837289B publication Critical patent/CN109837289B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了一种调控纳豆芽孢杆菌自凝集能力和菌膜特性的方法。该方法通过改变非特异性DNA结合蛋白HBsu编码基因表达水平和蛋白表达量达到改变纳豆芽孢杆菌自凝集能力和菌膜特性,并进一步改变纳豆芽孢杆菌合成维生素K2的能力。本发明为维生素K2优良菌株的选育提供了一条新思路,在食品、生物制药领域具有较大的实际意义和广阔的应用前景。

Figure 201910233452

The invention discloses a method for regulating the self-agglutination ability and biofilm characteristics of Bacillus natto. The method can change the self-agglutination ability and biofilm characteristics of Bacillus natto by changing the expression level and protein expression level of the non-specific DNA-binding protein HBsu encoding gene, and further change the ability of Bacillus natto to synthesize vitamin K2. The invention provides a new idea for the selection and breeding of excellent strains of vitamin K2, and has great practical significance and broad application prospects in the fields of food and biopharmaceuticals.

Figure 201910233452

Description

Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto
Technical Field
The invention belongs to the technical field of industrial microbial strain modification, and particularly relates to a method for regulating and controlling the self-agglutination capability and the mycoderm characteristic of bacillus natto.
Background
As an important class of fat-soluble vitamins, vitamin K2Has important application in the fields of food and medicine. The health people are supplemented with appropriate amount of the health foodVitamin K2The food can effectively reduce the incidence of fracture. In addition, more and more data are showing vitamin K2Deficiency is a significant cause of bleeding disease and death in infants worldwide. In addition, in recent years, the research reports published by domestic and foreign scholars in top-level international periodicals such as Science and Nature show that similar to coenzyme Q, vitamin K2As a membrane-bound electron carrier, the compound has the function of repairing damaged cell mitochondria, which plays an important role in protecting human beings from Parkinson's disease. Due to the application of the three aspects, the international market aims at the functional food vitamin K2Has been increasing in recent years.
Researches show that a large amount of biofilms are generated by the self-agglutination of the static fermentation of the natto bacillus under the shake flask scale, and the formation of the biofilms obviously promotes the vitamin K2And (4) synthesizing. Therefore, the self-agglutination capability and the mycoderm characteristic of the bacillus natto are regulated and controlled, and the vitamin K is promoted2The anabolism of (2) has very important significance. However, the research on the self-agglutination capability and the mycoderm characteristics of the bacillus natto in China is still rarely reported at present.
Disclosure of Invention
The invention aims to solve the technical problems in the prior art. Therefore, the invention provides a method for regulating and controlling the self-agglutination capability and the mycoderm characteristic of the bacillus natto, the self-agglutination capability and the mycoderm forming capability of the bacillus natto are obviously enhanced by regulating and controlling the expression level and the protein amount of an HBsu coding gene, and the vitamin K is finally improved2The level of synthesis of (c).
In order to achieve the purpose, the invention adopts the technical scheme that:
a method for regulating the self-aggregation capability and the mycoderm characteristic of Bacillus natto comprises the following steps:
a. culturing the bacillus natto in an LB liquid culture medium;
b. extracting the whole genome of the bacillus natto;
c. designing a primer pair by taking a non-specific DNA binding protein HBsu coding gene as a target gene for overexpression, and carrying out PCR amplification on a target gene fragment of the whole genome of the bacillus natto;
d. connecting the target gene fragment with a vector to construct an enhanced vector for enhancing the activity of HBsu;
e. the enhanced vector is used for transforming the bacillus natto, transformants are screened by utilizing the resistance genes on the vector, and the screened transformants are transferred to a slant culture medium;
f. selecting a bacterial colony from a slant culture medium and culturing a mutant strain on a seed culture medium;
g. the self-agglutination capability and the mycoderm characteristic of the mutant strain are regulated and controlled by regulating the temperature of the mutant strain when IPTG is added for culture.
The method for regulating and controlling the self-cohesive capacity of the mutant strain in the step g comprises the following steps: firstly inoculating the mutant strain into a fermentation culture medium for culture, then adding IPTG (isopropyl-beta-D-thiogalactoside) for culture at 15-30 ℃ until OD600 is 3.0, then sequentially centrifuging, washing and resuspending, controlling OD600 to be 2.5, finally standing the resuspension solution for 24 hours, measuring the bacterial liquid OD600 at 1cm below each culture solution after self-agglutination, and calculating the self-agglutination rate, wherein the calculation formula of the self-agglutination rate is as follows:
AAg (%) (from OD600 of supernatant after agglutination-OD 600 before agglutination)/OD 600 before self agglutination × 100%.
Preferably, the original bacillus natto and the mutant strain are respectively inoculated into a fermentation medium, and the size of the self-aggregation characteristic of each strain is detected. The culture conditions were 37 ℃ for 2 days, IPTG was added to induce expression, and the cells were cultured at 15, 20, 25 and 30 ℃ until OD600 became 3.0. The cells were collected by centrifugation at 6000 Xg for 10min and washed twice with phosphate buffer. Finally, the cells were resuspended in phosphate buffer and the OD600 was controlled at 2.5. Placing 5mL of the heavy suspension in a glass test tube, standing for 24 hours at 4 ℃, and measuring the concentration of the bacterial liquid at a position 1cm below each culture liquid surface, wherein three samples are arranged in parallel.
The method for regulating and controlling the characteristics of the bacterial membrane in the step g comprises the following steps: firstly, culturing the mutant strain in an LB culture medium at 37 ℃ until OD600 is 0.02, then transferring to a fermentation culture medium for culturing until OD600 is 2.0, adding IPTG (isopropyl-beta-thiogalactoside) for shaking culture at 15-30 ℃, then removing a culture solution, sequentially washing, dyeing, standing, washing again until no purple color exists, finally adding acetic acid for treatment, and measuring the absorbance of the obtained solution under the visible light of 597nm (taking the original bacteria as a blank control), and recording the absorbance as the rate of mycoderm formation.
Preferably, the original bacillus natto and the mutant strain are taken as research objects, the bacillus natto and the mutant strain are cultured in LB culture medium until OD600 is 0.02, the bacillus natto and the mutant strain are transferred to a 5mL test tube containing TSB culture medium, IPTG is added when the bacillus natto and the mutant strain are cultured until OD600 is 2.0, the IPTG is added for culture, after shaking culture at 15, 20, 25 and 30 ℃ for 24 hours, the culture in the test tube is slowly removed, the test tube is washed by distilled water for 2-3 times, 3mL crystal violet solution (w/v%) with the mass volume ratio of 0.1% is added for staining after air drying, the test tube is kept still for 20min at room temperature, the stain is poured out, then the test tube is washed by distilled water for 2-3 times, floating color is washed, the test tube is inversely dried for 20min, residual moisture is removed, finally 2mL of 33% acetic acid (v/v%) is added for ultrasonic decolorization for 10min, the volume fraction of 33% acetic acid is taken as reference, and the absorbance of the obtained solution is measured under the visible light of 597nm (taking the original strain as the blank rate, and the strain film forming rate is taken as the reference.
Inoculating original Bacillus natto and mutant strain into fermentation medium, culturing at 37 deg.C for 2 days, adding IPTG, culturing at 15, 20, 25, and 30 deg.C for 3-5 days, and measuring vitamin K in fermentation liquid2And (4) yield. And detecting the expression level of hbs in each strain by reverse transcription PCR or fluorescent quantitative PCR. Determination of vitamin K in fermentation broth2The content is measured by HPLC, and the fluorescent quantitative PCR detection is carried out by SYBR Green Real-Time qPCR kit.
The fermentation medium is TSB, and the components (w/v%) are as follows: 17g of tryptone, 3g of soybean papain digest, 5g of sodium chloride, 2.5g of potassium dihydrogen phosphate and 2.5g of glucose.
And c, adding restriction enzyme cutting sites and protective base sequences of restriction enzymes on two sides of the target gene segment in the step c.
The vector in the step d is an inducible expression vector.
The mode of transforming the bacillus natto by the vector in the step e can be electro-stimulation transformation, protoplast transformation mediated by polyethylene glycol, isopropanol transformation or dimethyl sulfoxide transformation.
And e, selecting ampicillin and tetracycline resistance in the resistance gene screening in the step e.
The HBsu gene is SEQ ID No: 1, or a nucleotide sequence represented by the formula (I).
The primer pair in the step c is SEQ ID No: 2 and SEQ ID No: 3.
The self-agglutination capability and the pellicle characteristics of the bacillus natto are changed by changing the expression level and the protein expression quantity of a non-specific DNA binding protein HBsu coding gene. The mode of change is that the self-agglutination capability and the bacterial membrane characteristic of the natto bacillus are regulated and controlled by the expression level of over-expression non-specific DNA binding protein.
The method changes the vitamin K synthesized by the bacillus natto by adjusting the self-aggregation capability and the mycoderm characteristics of the bacillus natto2The ability of the cell to perform.
The invention has the beneficial effects that: according to the invention, the self-agglutination capability and the bacterial membrane characteristic of the bacillus natto are regulated and controlled through the expression level of over-expression non-specific DNA binding protein, so that a mutant strain capable of enriching and generating a biological membrane is obtained; the mutant strain obtained by the invention has greatly improved self-agglutination rate, prolonged logarithmic growth phase of the strain and improved biofilm formation capability. After the biofilm forms in the later stage of fermentation, vitamin K2The yield is also obviously improved. The method regulates and controls the expression level of nonspecific DNA binding protein (HBsu) by temperature induction, and finally influences the synthesis of vitamin K by Bacillus natto2The ability of the cell to perform. The invention is vitamin K2The breeding of the excellent strain provides a new idea, and has great practical significance and wide application prospect in the fields of food and biological pharmacy.
Drawings
The description includes the following figures, the contents shown are respectively:
FIG. 1 shows that different expression levels of hbs gene were measured by fluorescence quantitative PCR for original strain and mutant strains obtained at different induction temperatures;
FIG. 2 shows that different expression levels of HBsu were measured by Western blot for original bacteria and mutants obtained at different induction temperatures.
Detailed Description
The following examples are included to provide further detailed description of the embodiments of the invention and to provide those skilled in the art with a more complete, concise and complete understanding of the principles and spirit of the invention, and to facilitate its practice.
Example 1
Taking bacillus natto BS-13 as an original strain, and sequentially operating according to the following steps:
1. culturing the bacillus natto in 50mL LB culture medium and culturing for 48h at 37 ℃ by a shaking table.
2. Collecting culture solution, centrifuging, collecting thallus precipitate, extracting genome DNA with kit, and storing at-20 deg.C.
3. The nonspecific DNA binding protein HBsu coding gene hbs is used as a target gene, and primer pairs are designed as follows:
Primer-F 5'-GCGTCGACATGAACAAAACAGAACTTATCAATGCG 3'(SEQ ID No:2)
Primer-R 5'-GAATTCCGTTATTTTCCGGCAACTGCGTCTTTAAG 3'(SEQ ID No:3)
PCR amplification was performed using Taq DNA polymerase using genomic DNA as a template, and the desired fragment was approximately 279 bp.
4. The vector pHY-P43 was used to transform Bacillus subtilis WB600 competent cells, spread on ampicillin and tetracycline resistant plates, and incubated overnight (12-16h) in a 37 ℃ incubator. Picking single colony from the transformation plate, extracting plasmid with plasmid extraction kit after liquid culture, and storing at-20 ℃.
5. The vector and the target fragment are cut by SalI and EcoRI respectively and then are connected into an enhanced vector pHY-P43 under the action of T4DNA ligase.
6. The obtained enhanced vector enters the bacillus natto BS-13 by an electrotransformation method, transformants are screened by ampicillin and tetracycline resistance, and the screened transformants are transferred to a slant culture medium for storage.
7. Colonies were picked from the slant medium and cultured in 50mL of LB seed medium in a 37 ℃ incubator for 48 hours.
8. Inoculating the bacillus natto mutant strain liquid into 500mL conical flasks containing 50mL fermentation medium according to the inoculation amount of 5%, and culturing for 2 days at 37 ℃ at 220 r/min. The fermentation medium was TSB, with the composition (w/v%): 17g of tryptone, 3g of soybean papain digest, 5g of sodium chloride, 2.5g of potassium dihydrogen phosphate and 2.5g of glucose. The cells were collected by centrifugation at 6000 Xg for 10min after adding IPTG at 15 ℃ and then cultured until OD600 became 3.0, and the cells were washed twice with a phosphate buffer. Finally, the cells were resuspended in phosphate buffer, and the OD600 of the cells before self-agglutination was controlled to 2.5. Placing 5mL of the heavy suspension in a glass test tube, standing at 4 ℃ for 24 hours, and determining that the bacterial liquid OD600 at 1cm under the culture liquid after self-agglutination is 5.5-6.5, and the self-agglutination rate of the mutant strain is 160-.
9. Culturing Bacillus natto BS-13 and mutant strain LB culture medium until OD600 is 0.02, transferring to 5mL test tube containing TSB culture medium, culturing until OD600 is 2.0, adding IPTG (isopropyl thiogalactoside) for culturing, after shaking culturing for 24 hours at 15 ℃, slowly removing the culture in the test tube, washing with distilled water for 2-3 times, drying in the air, adding 3mL of crystal violet solution (w/v%) with the mass volume ratio of 0.1% for dyeing, standing at room temperature for 20min, washing with distilled water for 2-3 times after pouring off the dyeing agent, washing off the floating color, inverting and drying in the air for 20min, removing residual moisture, finally adding 2mL of 33% acetic acid (v/v%), performing ultrasonic decoloration for 10min by taking the volume fraction of 33% acetic acid as a reference, the absorbance of the obtained solution is measured under the visible light of 597nm, and the mutant strain bacterial film forming rate (taking Bacillus natto BS-13 as a blank control) OD597 is 1.3-1.8.
10. Inoculating Bacillus natto BS-13 and mutant strain into fermentation medium, culturing at 37 deg.C for 2 days, adding IPTG, culturing at 15 deg.C for 3-5 days, and culturing to obtain mutant strain vitamin K2The yield is 37.8-59.4mg/L, which is improved by 2.1-3.3 times compared with BS-13.
Example 2
Taking bacillus natto BS-13 as an original strain, and sequentially operating according to the following steps:
1. culturing the bacillus natto in 50mL LB culture medium and culturing for 48h at 37 ℃ by a shaking table.
2. Collecting culture solution, centrifuging, collecting thallus precipitate, extracting genome DNA with kit, and storing at-20 deg.C.
3. The nonspecific DNA binding protein HBsu coding gene hbs is used as a target gene, and primer pairs are designed as follows:
Primer-F 5'-GCGTCGACATGAACAAAACAGAACTTATCAATGCG 3'(SEQ ID No:2)
Primer-R 5'-GAATTCCGTTATTTTCCGGCAACTGCGTCTTTAAG 3'(SEQ ID No:3)
PCR amplification was performed using Taq DNA polymerase using genomic DNA as a template, and the desired fragment was approximately 279 bp.
4. The vector pHY-P43 was used to transform Bacillus subtilis WB600 competent cells, spread on ampicillin and tetracycline resistant plates, and incubated overnight (12-16h) in a 37 ℃ incubator. Picking single colony from the transformation plate, extracting plasmid with plasmid extraction kit after liquid culture, and storing at-20 ℃.
5. The vector and the target fragment are cut by SalI and EcoRI respectively and then are connected into an enhanced vector pHY-P43 under the action of T4DNA ligase.
6. The obtained enhanced vector enters the bacillus natto BS-13 by an electrotransformation method, transformants are screened by ampicillin and tetracycline resistance, and the screened transformants are transferred to a slant culture medium for storage.
7. Colonies were picked from the slant medium and cultured in 50mL of LB seed medium in a 37 ℃ incubator for 48 hours.
8. Inoculating the bacillus natto mutant strain liquid into 500mL conical flasks containing 50mL fermentation medium according to the inoculation amount of 5%, and culturing for 2 days at 37 ℃ at 220 r/min. The fermentation medium was TSB, with the composition (w/v%): 17g of tryptone, 3g of soybean papain digest, 5g of sodium chloride, 2.5g of potassium dihydrogen phosphate and 2.5g of glucose. The cells were collected by centrifugation at 6000 Xg for 10min after adding IPTG at 20 ℃ and then cultured until OD600 became 3.0, and the cells were washed twice with a phosphate buffer. Finally, the cells were resuspended in phosphate buffer, and the OD600 of the cells before self-agglutination was controlled to 2.5. Placing 5mL of the heavy suspension in a glass test tube, standing at 4 ℃ for 24 hours, and determining that the bacterial liquid OD600 at 1cm under the culture liquid after self-agglutination is 5.2-7.0, and the self-agglutination rate of the mutant strain is 110-180%.
9. Culturing Bacillus natto BS-13 and mutant strain LB culture medium until OD600 is 0.02, transferring to 5mL test tube containing TSB culture medium, culturing until OD600 is 2.0, adding IPTG (isopropyl thiogalactoside) for culturing, after shaking culturing for 24 hours at 20 ℃, slowly removing the culture in the test tube, washing with distilled water for 2-3 times, drying in the air, adding 3mL of crystal violet solution (w/v%) with the mass volume ratio of 0.1% for dyeing, standing at room temperature for 20min, washing with distilled water for 2-3 times after pouring off the dyeing agent, washing off the floating color, inverting and drying in the air for 20min, removing residual moisture, finally adding 2mL of 33% acetic acid (v/v%), performing ultrasonic decoloration for 10min by taking the volume fraction of 33% acetic acid as a reference, the absorbance of the obtained solution is measured under the visible light of 597nm, and the mutant strain bacterial film forming rate (taking Bacillus natto BS-13 as a blank control) OD597 is 1.2-2.6.
10. Inoculating Bacillus natto BS-13 and mutant strain into fermentation medium, culturing at 37 deg.C for 2 days, adding IPTG, culturing at 20 deg.C for 3-5 days, and culturing to obtain mutant strain vitamin K2The yield is 50.4-77.4mg/L, which is improved by 2.8-4.3 times compared with BS-13.
Example 3
Taking bacillus natto BS-13 as an original strain, and sequentially operating according to the following steps:
1. culturing the bacillus natto in 50mL LB culture medium and culturing for 48h at 37 ℃ by a shaking table.
2. Collecting culture solution, centrifuging, collecting thallus precipitate, extracting genome DNA with kit, and storing at-20 deg.C.
3. The nonspecific DNA binding protein HBsu coding gene hbs is used as a target gene, and primer pairs are designed as follows:
Primer-F 5'-GCGTCGACATGAACAAAACAGAACTTATCAATGCG 3'(SEQ ID No:2)
Primer-R 5'-GAATTCCGTTATTTTCCGGCAACTGCGTCTTTAAG 3'(SEQ ID No:3)
PCR amplification was performed using Taq DNA polymerase using genomic DNA as a template, and the desired fragment was approximately 279 bp.
4. The vector pHY-P43 was used to transform Bacillus subtilis WB600 competent cells, spread on ampicillin and tetracycline resistant plates, and incubated overnight (12-16h) in a 37 ℃ incubator. Picking single colony from the transformation plate, extracting plasmid with plasmid extraction kit after liquid culture, and storing at-20 ℃.
5. The vector and the target fragment are cut by SalI and EcoRI respectively and then are connected into an enhanced vector pHY-P43 under the action of T4DNA ligase.
6. The obtained enhanced vector enters the bacillus natto BS-13 by an electrotransformation method, transformants are screened by ampicillin and tetracycline resistance, and the screened transformants are transferred to a slant culture medium for storage.
7. Colonies were picked from the slant medium and cultured in 50mL of LB seed medium in a 37 ℃ incubator for 48 hours.
8. Inoculating the bacillus natto mutant strain liquid into 500mL conical flasks containing 50mL fermentation medium according to the inoculation amount of 5%, and culturing for 2 days at 37 ℃ at 220 r/min. The fermentation medium was TSB, with the composition (w/v%): 17g of tryptone, 3g of soybean papain digest, 5g of sodium chloride, 2.5g of potassium dihydrogen phosphate and 2.5g of glucose. The cells were collected by centrifugation at 6000 Xg for 10min after adding IPTG at 25 ℃ and then cultured until OD600 became 3.0, and the cells were washed twice with a phosphate buffer. Finally, the cells were resuspended in phosphate buffer, and the OD600 of the cells before self-agglutination was controlled to 2.5. Placing 5mL of the heavy suspension in a glass test tube, standing at 4 ℃ for 24 hours, and determining that the bacterial liquid OD600 at 1cm under the culture liquid after self-agglutination is 5.2-6.3, and the self-agglutination rate of the mutant strain is 110-150%.
9. Culturing Bacillus natto BS-13 and mutant strain LB culture medium until OD600 is 0.02, transferring to 5mL test tube containing TSB culture medium, culturing until OD600 is 2.0, adding IPTG (isopropyl thiogalactoside) for culturing, after shaking culturing for 24 hours at 25 ℃, slowly removing the culture in the test tube, washing with distilled water for 2-3 times, drying in the air, adding 3mL of crystal violet solution (w/v%) with the mass volume ratio of 0.1% for dyeing, standing at room temperature for 20min, washing with distilled water for 2-3 times after pouring off the dyeing agent, washing off the floating color, inverting and drying in the air for 20min, removing residual moisture, finally adding 2mL of 33% acetic acid (v/v%), performing ultrasonic decoloration for 10min by taking the volume fraction of 33% acetic acid as a reference, the absorbance of the obtained solution is measured under the visible light of 597nm, and the mutant strain bacterial film forming rate (taking Bacillus natto BS-13 as a blank control) OD597 is 1.4-2.1.
10. Inoculating Bacillus natto BS-13 and mutant strain into fermentation medium, culturing at 37 deg.C for 2 days, adding IPTG, culturing at 25 deg.C for 3-5 days, and culturing to obtain mutant strain vitamin K2The yield is 32.4-43.2mg/L, which is improved by 1.8-2.4 times compared with BS-13.
Example 4
Taking bacillus natto BS-13 as an original strain, and sequentially operating according to the following steps:
1. culturing the bacillus natto in 50mL LB culture medium at 37 ℃ for 48h by a shaking table;
2. collecting culture solution, centrifuging, collecting thallus precipitate, extracting genome DNA with kit, and storing at-20 deg.C.
3. The nonspecific DNA binding protein HBsu coding gene hbs is used as a target gene, and primer pairs are designed as follows:
Primer-F 5'-GCGTCGACATGAACAAAACAGAACTTATCAATGCG 3'(SEQ ID No:2)
Primer-R 5'-GAATTCCGTTATTTTCCGGCAACTGCGTCTTTAAG 3'(SEQ ID No:3)
PCR amplification was performed using Taq DNA polymerase using genomic DNA as a template, and the desired fragment was approximately 279 bp.
4. The vector pHY-P43 was used to transform Bacillus subtilis WB600 competent cells, spread on ampicillin and tetracycline resistant plates, and incubated overnight (12-16h) in a 37 ℃ incubator. Picking single colony from the transformation plate, extracting plasmid with plasmid extraction kit after liquid culture, and storing at-20 ℃.
5. The vector and the target fragment are cut by SalI and EcoRI respectively and then are connected into an enhanced vector pHY-P43 under the action of T4DNA ligase.
6. The obtained enhanced vector enters the bacillus natto BS-13 by an electrotransformation method, transformants are screened by ampicillin and tetracycline resistance, and the screened transformants are transferred to a slant culture medium for storage.
7. Colonies were picked from the slant medium and cultured in 50mL of LB seed medium in a 37 ℃ incubator for 48 hours.
8. Inoculating the bacillus natto mutant strain liquid into 500mL conical flasks containing 50mL fermentation medium according to the inoculation amount of 5%, and culturing for 2 days at 37 ℃ at 220 r/min. The fermentation medium was TSB, with the composition (w/v%): 17g of tryptone, 3g of soybean papain digest, 5g of sodium chloride, 2.5g of potassium dihydrogen phosphate and 2.5g of glucose. The cells were collected by centrifugation at 6000 Xg for 10min after adding IPTG at 30 ℃ and then cultured until OD600 became 3.0, and the cells were washed twice with a phosphate buffer. Finally, the cells were resuspended in phosphate buffer, and the OD600 of the cells before self-agglutination was controlled to 2.5. Placing 5mL of the heavy suspension in a glass test tube, standing at 4 ℃ for 24 hours, and determining that the bacterial liquid OD600 at 1cm under the culture liquid after self-agglutination is 5.1-5.8, and the self-agglutination rate of the mutant strain is 130-.
9. Culturing Bacillus natto BS-13 and mutant strain LB culture medium until OD600 is 0.02, transferring to 5mL test tube containing TSB culture medium, culturing until OD600 is 2.0, adding IPTG (isopropyl thiogalactoside) for culturing, after shaking culturing for 24 hours at 30 ℃, slowly removing the culture in the test tube, washing with distilled water for 2-3 times, drying in the air, adding 3mL of crystal violet solution (w/v%) with the mass volume ratio of 0.1% for dyeing, standing at room temperature for 20min, washing with distilled water for 2-3 times after pouring off the dyeing agent, washing off the floating color, inverting and drying in the air for 20min, removing residual moisture, finally adding 2mL of 33% acetic acid (v/v%), performing ultrasonic decoloration for 10min by taking the volume fraction of 33% acetic acid as a reference, the absorbance of the obtained solution is measured under the visible light of 597nm, and the mutant strain bacterial film forming rate (taking Bacillus natto BS-13 as a blank control) OD597 is 1.1-1.6.
10. Inoculating Bacillus natto BS-13 and mutant strain into fermentation medium, culturing at 37 deg.C for 2 days, adding IPTG, culturing at 30 deg.C for 3-5 days, and culturing to obtain mutant strain vitamin K2The yield is 21.6-34.2mg/L, which is improved by 1.2-1.9 times compared with BS-13.
The invention adopts an overexpression mode, regulates and controls the self-agglutination capability and the mycoderm characteristic of the bacillus natto by regulating the overexpression level of the temperature control hbs and the protein overexpression amount of the nonspecific DNA binding protein (HBsu) (shown in attached figures 1 and 2), and finally influences the synthesis of vitamin K by the bacillus natto2The ability of the cell to perform.
The present invention has been described above by way of example. It is to be understood that the specific implementations of the invention are not limited in this respect. Various insubstantial improvements are made by adopting the method conception and the technical scheme of the invention; the present invention is not limited to the above embodiments, and can be modified in various ways.
SEQUENCE LISTING
<110> university of Anhui engineering
<120> a method for regulating the self-aggregation capability and the mycoderm characteristic of bacillus natto
<130> 1
<160> 3
<170> PatentIn version 3.3
<210> 1
<211> 279
<212> DNA
<213> Bacillus natto hbs
<400> 1
atgaacaaaa cagaacttat caatgcggtt gcagaagcaa gcgaattgtc taaaaaagac 60
gctacaaaag cagttgactc tgtttttgat acgatcttag atgcacttaa aaacggtgat 120
aaaatccaac tgatcggttt tggtaacttc gaggtgcgtg aacgttctgc acgtaaagga 180
cgcaaccctc aaacaggtga agaaatcgaa attccagcga gcaaagtacc tgctttcaaa 240
ccaggtaaag cgcttaaaga cgcagttgcc ggaaaataa 279
<210> 2
<211> 35
<212> DNA
<213> Artificial sequence
<400> 2
gcgtcgacat gaacaaaaca gaacttatca atgcg 35
<210> 3
<211> 35
<212> DNA
<213> Artificial sequence
<400> 3
gaattccgtt attttccggc aactgcgtct ttaag 35

Claims (1)

1.一种调节纳豆芽孢杆菌自凝聚能力和菌膜特性的方法,其特征在于,包括如下步骤:1. a method for regulating Bacillus natto self-aggregation ability and biofilm characteristic, is characterized in that, comprises the steps: a、将纳豆芽孢杆菌在LB液体培养基中培养;a. Bacillus natto is cultivated in LB liquid medium; b、提取纳豆芽孢杆菌全基因组;b. Extract the whole genome of Bacillus natto; c、以非特异性DNA结合蛋白HBsu编码基因为目的基因设计引物对进行过表达,对纳豆芽孢杆菌全基因组进行PCR扩增目的基因片段;c. Design primer pairs with the non-specific DNA binding protein HBsu encoding gene as the target gene to overexpress, and carry out PCR amplification of the target gene fragment for the whole genome of Bacillus natto; 目的基因片段两侧加有限制性内切酶的酶切位点和保护碱基序列;Both sides of the target gene fragment are added with restriction endonuclease enzyme cleavage sites and protective base sequences; 所述HBsu编码基因是SEQ ID No:1所示的碱基序列;The HBsu encoding gene is the base sequence shown in SEQ ID No: 1; 所述引物对为SEQ ID No:2和SEQ ID No:3所示的核苷酸序列;The primer pair is the nucleotide sequence shown in SEQ ID No: 2 and SEQ ID No: 3; d、将目的基因片段与载体连接构建用于增强HBsu活性的pHY-P43增强载体;d. Linking the target gene fragment with the vector to construct a pHY-P43 enhancing vector for enhancing the activity of HBsu; e、增强载体转化纳豆芽孢杆菌,并利用载体上的抗性基因筛选转化子,将筛选到的转化子转接到斜面培养基上;E, enhance the vector transformation Bacillus natto, and utilize the resistance gene on the carrier to screen transformants, and transfer the screened transformants to the slant medium; 抗性基因筛选选用的是氨苄青霉素和四环素抗性;The selection of resistance gene selection is ampicillin and tetracycline resistance; f、从斜面培养基上挑取菌落在种子培养基上进行培养转化株;F, pick colony from slant medium and carry out culture transformant on seed medium; g、将纳豆芽孢杆菌及转化株分别接入发酵培养基,通过调节IPTG培养时的温度改变非特异性DNA结合蛋白HBsu编码基因表达水平和蛋白表达量,以调控转化株自凝集能力和菌膜特性,进而改变纳豆芽孢杆菌合成维生素K2的能力;g. Bacillus natto and the transformant were respectively inserted into the fermentation medium, and the expression level and protein expression of the non-specific DNA-binding protein HBsu encoding gene were changed by adjusting the temperature during IPTG culture, so as to regulate the self-agglutination ability and the biofilm of the transformant. characteristics, thereby changing the ability of Bacillus natto to synthesize vitamin K 2 ; 调控转化株自凝聚能力的方法为:先将转化株接入发酵培养基中培养,之后加入IPTG在15-30℃培养至OD600=3.0,然后依次经离心、洗涤、重悬,并控制OD600=2.5,最后将重悬液静置24小时后测定自凝集后各培养液下1cm处的菌液OD600,计算得出自凝集率,自凝集率的计算公式为:The method for regulating the self-aggregation ability of the transformant is as follows: firstly insert the transformant into the fermentation medium for cultivation, then add IPTG at 15-30°C to cultivate to OD600=3.0, and then perform centrifugation, washing and resuspension in sequence, and control OD600= 2.5. Finally, after standing the resuspended liquid for 24 hours, measure the OD600 of the bacterial liquid at 1 cm below each culture solution after self-agglutination, and calculate the self-agglutination rate. The calculation formula of the self-agglutination rate is: AAg(%)=(自凝集后上层菌液OD600-自凝集前OD600)/自凝集前OD600 ×100%;AAg (%)=(OD600 of upper bacterial solution after self-agglutination-OD600 before self-agglutination)/OD600 before self-agglutination ×100%; 调控菌膜特性的方法为:先将转化株在LB培养基中培养至OD600=0.02,之后转接至发酵培养基培养至OD600=2.0时,加入IPTG在15-30℃振荡培养,然后移出培养液,依次经洗涤、染色、静置、再次洗涤至无紫色,最后加入乙酸处理,在可见光597nm下测定所得溶液的吸光度,记为菌膜形成率;The method of regulating the biofilm characteristics is as follows: firstly culture the transformant in LB medium to OD600=0.02, then transfer to fermentation medium and cultivate to OD600=2.0, add IPTG for shaking culture at 15-30℃, and then remove the culture The solution was washed, dyed, left to stand, washed again until no purple color, and finally added acetic acid for treatment, and the absorbance of the obtained solution was measured under visible light 597 nm, which was recorded as the biofilm formation rate; 其中加入IPTG转20°C培养时,转化株维生素K2产量为50.4-77.4 mg/L,较原始菌种提高2.8-4.3倍。Wherein, when IPTG was added and transferred to 20°C for culture, the vitamin K output of the transformant was 50.4-77.4 mg/L, which was 2.8-4.3 times higher than that of the original strain.
CN201910233452.7A 2019-03-26 2019-03-26 Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto Active CN109837289B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910233452.7A CN109837289B (en) 2019-03-26 2019-03-26 Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910233452.7A CN109837289B (en) 2019-03-26 2019-03-26 Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto

Publications (2)

Publication Number Publication Date
CN109837289A CN109837289A (en) 2019-06-04
CN109837289B true CN109837289B (en) 2021-12-28

Family

ID=66886436

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910233452.7A Active CN109837289B (en) 2019-03-26 2019-03-26 Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto

Country Status (1)

Country Link
CN (1) CN109837289B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110656136B (en) * 2019-10-25 2021-08-17 江南大学 A kind of method that utilizes starch to produce menaquinone-7
CN111349639A (en) * 2020-01-17 2020-06-30 西宝生物科技(上海)股份有限公司 High-efficiency biosynthesis vitamin K for improving bacillus natto2(MK-7) method
CN114250240B (en) * 2021-12-27 2023-07-28 安徽工程大学 A method for regulating the morphology of Escherichia coli membrane and efficiently synthesizing MK-7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4104741B2 (en) * 1998-09-08 2008-06-18 旭松食品株式会社 Vitamin K high-producing strain and method for producing vitamin K using the same
JP4264159B2 (en) * 1999-04-07 2009-05-13 株式会社ミツカングループ本社 Vitamin K2 high productivity natto, its breeding method and natto
JP2008113633A (en) * 2006-11-08 2008-05-22 Mitsukan Group Honsha:Kk Bacillus natto highly producing vitamin b2 and natto product produced by using the bacillus natto
CN104328064B (en) * 2014-09-16 2017-08-11 丽水双健生物工程有限公司 A kind of bafillus natto and its application in fermenting and producing farnoquinone
CN106222208A (en) * 2016-08-01 2016-12-14 安徽工程大学 A method for improving extracellular secretion of vitamin K2

Also Published As

Publication number Publication date
CN109837289A (en) 2019-06-04

Similar Documents

Publication Publication Date Title
CN109837289B (en) Method for adjusting self-aggregation capability and mycoderm characteristics of bacillus natto
CN104630258B (en) A kind of genes of brewing yeast expression system and its structure and application
CN107815446B (en) A kind of fermentation process in high density of recombination nitrile hydratase Recombinant organism
CN106754466A (en) It is a kind of for efficient exogenous protein expression and the bacillus subtilis of High Density Cultivation
CN111117942B (en) Genetic engineering bacterium for producing lincomycin and construction method and application thereof
CN110669709A (en) A method for efficient synthesis of PHB by knocking out flagella and fimbriae genes
CN104878024A (en) Recombinant Escherichia coli construction and (S)-2-hydroxy-3-phenylpropionic acid synthesis method
CN105441517A (en) Identification and Application of Synthetic Gene Cluster of Cordycepin
CN102690841B (en) A genetic transformation method for obtaining transgenic callus of Taxus chinensis
CN104593407B (en) Pichia stipitis gene expression system and its structure and application
KR102473375B1 (en) Recombinant microorganisms, their preparation methods and their use in the production of coenzyme Q10
CN110029069B (en) Saccharopolyspora sinensis engineering strain with light flavomycin gene cluster knocked out and application thereof
CN108220219A (en) A set of lactobacillus plantarum food-grade expression system and its application in heterologous protein expression
CN104805048B (en) The escherichia coli of one plant of detection lead
CN112251456B (en) A method for improving the yield of lincomycin by Streptomyces lincolis regulatory gene combination modification
CN108641992A (en) The riboflavin-produced engineering bacteria of high temperature and its construction method and application
CN117737066A (en) Transcription regulatory sequence and application thereof
Droffner et al. Prolonged environmental stress via a two step process selects mutants of Escherichia, Salmonella and Pseudomonas that grow at 54 C
CN110951760A (en) Protein time-delay expression switch and application thereof in production of glucaric acid
CN104711237B (en) A kind of method of regulation and control 1,4- dihydroxy-2-naphthoic acids-polyisoprene transfer enzyme activity
CN116064522A (en) Temperature-inducible promoter derived from Bacillus amyloliquefaciens and its application
CN116064521A (en) PH-induced promoter derived from bacillus amyloliquefaciens and application thereof
CN107245471A (en) It is a kind of to recombinate streptomyces hygroscopicus and its application in jinggangmycin A yield is improved
CN109929853B (en) Application of heat shock protein gene derived from thermophilic bacteria
CN114891806A (en) Citrobacter williamsii yqjH gene knockout mutant strain and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant